
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors”, Arch Intern Med, vol. 154, pp. 311-6, 1994.
, “Acute respiratory-tract infections and risk of first-time acute myocardial infarction”, Lancet, vol. 351, pp. 1467-71, 1998.
, “Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer”, Arch Intern Med, vol. 160, pp. 349-53, 2000.
, “Antibiotics and risk of subsequent first-time acute myocardial infarction”, Jama, vol. 281, pp. 427-31, 1999.
, “Antidepressant drugs and suicide”, J Clin Psychopharmacol, vol. 12, pp. 235-40, 1992.
, “Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension”, Epidemiology, vol. 8, pp. 446-8, 1997.
, “Appendectomy protects against ulcerative colitis”, Epidemiology, vol. 9, pp. 205-7, 1998.
, “Cholestatic hepatitis associated with flucloxacillin”, Med J Aust, vol. 158, pp. 596-600, 1993.
, “A comparison of the risk of hypoglycemia between users of human and animal insulins. 1. Experience in the United Kingdom”, Pharmacotherapy, vol. 10, pp. 395-7, 1990.
, “Erythromycin-associated cholestatic hepatitis”, Med J Aust, vol. 158, pp. 600-2, 1993.
, “Flucloxacillin and cholestatic hepatitis”, Med J Aust, vol. 160, p. 525, 1994.
, “The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data”, Br J Cancer, vol. 83, pp. 1556-8, 2000.
, “A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity”, Pharmacotherapy, vol. 15, pp. 428-32, 1995.
, “Liver disease associated with diclofenac, naproxen, and piroxicam”, Pharmacotherapy, vol. 12, pp. 207-12, 1992.
, “Liver disorders in patients receiving chlorpromazine or isoniazid”, Pharmacotherapy, vol. 13, pp. 353-8, 1993.
, “Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study”, Pharmacotherapy, vol. 13, pp. 212-7, 1993.
, “A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation”, N Engl J Med, vol. 339, pp. 719-24, 1998.
, “Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease”, Arch Neurol, vol. 58, pp. 435-40, 2001.
, “The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension”, Pharmacotherapy, vol. 16, pp. 321-6, 1996.
, “The risk of seizures associated with tramadol”, Pharmacotherapy, vol. 18, pp. 607-11, 1998.
, “Risk of suicide among users of calcium channel blockers: population based, nested case-control study”, Bmj, vol. 320, p. 1251, 2000.
, “Sudden unexplained death among subjects with refractory epilepsy”, Epilepsia, vol. 37, pp. 931-5, 1996.
, “Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke”, Br J Clin Pharmacol, vol. 47, pp. 565-9, 1999.
, “Validation of information recorded on general practitioner based computerised data resource in the United Kingdom”, Bmj, vol. 302, pp. 766-8, 1991.
,